Status:
RECRUITING
Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients
Lead Sponsor:
Universidad Nacional Autonoma de Mexico
Collaborating Sponsors:
Instituto Mexicano del Seguro Social
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Conditions:
Neuroendocrine Neoplasm
Neuroendocrine Neoplasm of Gastrointestinal Tract
Eligibility:
All Genders
18+ years
Brief Summary
Neuroendocrine neoplasms (NENs) are a heterogeneous group of lesions derived from cells with the ability to produce hormones that may arise from multiple different organs. Their clinical behavior is q...
Detailed Description
Introduction. NENs are a heterogeneous group of human neoplasms with a variable clinical behavior, spanning from indolence to frank aggressiveness and malignancy. They arise from various tissues with...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Adult patients with a new or previous clinical diagnosis of any of the following conditions:
- Isolated NENs with sporadic presentation, including bronchopulmonary NENs, gastrointestinal NENs, medullary thyroid carcinoma, pancreatic NENs, paragangliomas, pheochromocytomas, pituitary neuroendocrine tumors, and primary hyperparathyroidism.
- Familial isolated NENs, including familial isolated pituitary adenoma, familial pheochromocytomas and paragangliomas, familial primary hyperparathyroidism, familial gastrointestinal stromal tumors and X-linked acrogigantism.
- Clinical syndromes encompassing NENs, with familial or sporadic presentation, including Carney complex, Carney-Stratakis syndrome, Carney triad, Cowden syndrome, DICER1 syndrome, Li-Fraumeni syndrome, Lynch syndrome, multiple endocrine neoplasia type 1, multiple endocrine neoplasia type 2, multiple endocrine neoplasia type 4, neurofibromatosis type 1, Pacak-Zhuang syndrome, paraganglioma, pheochromocytoma and pituitary adenoma syndrome, tuberous sclerosis complex, Von Hippel Lindau syndrome.
- Exclusion criteria:
- Age \<18 years.
- Refusal to give informed consent.
Exclusion
Key Trial Info
Start Date :
August 3 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2037
Estimated Enrollment :
750 Patients enrolled
Trial Details
Trial ID
NCT06523582
Start Date
August 3 2022
End Date
March 1 2037
Last Update
July 26 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social
Mexico City, Mexico City, Mexico, 06720
2
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
Mexico City, Mexico City, Mexico, 14080
3
Red de Apoyo a la Investigación, Coordinación de la Investigación Científica, Universidad Nacional Autónoma de México
Mexico City, Mexico City, Mexico, 14080